Characterization of Bothrojaracin Interaction with Human Prothrombin

Overview

Journal Protein Sci

Specialty Biochemistry

Date 2001 Aug 22

PMID 11514680

Citations 6

Authors

R Q Monteiro

P E Bock

M L Bianconi

R B Zingali

Affiliations

Soon will be listed here.

Abstract

Bothrojaracin (BJC) is a 27-kD snake venom protein from Bothrops jararaca that has been characterized as a potent thrombin inhibitor. BJC binds to exosites I and II, with a dissociation constant of 0.7 nM, and influences but does not block the proteinase catalytic site. BJC also binds prothrombin through an interaction that has not been characterized. In the present work we characterize the interaction of BJC with prothrombin quantitatively for the first time, and identify the BJC binding site on human prothrombin. Gel filtration chromatography demonstrated calcium-independent, 1:1 complex formation between fluorescein-labeled BJC ([5F]BJC) and prothrombin, whereas no interactions were observed with activation fragments 1 or 2 of prothrombin. Isothermal titration calorimetry showed that binding of BJC to prothrombin is endothermic, with a dissociation constant of 76 +/- 32 nM. The exosite I-specific ligand, hirudin(54-65) (Hir(54-65) (SO(3)(-)), displaced competitively [5F]BJC from prothrombin. Titration of the fluorescent hirudin(54-65) derivative, [5F]Hir(54-65)(SO(3)(-)), with human prothrombin showed a dissociation constant of 7.0 +/- 0.2 microM, indicating a approximately 100-fold lower binding affinity than that exhibited by BJC. Both ligands, however, displayed a similar, approximately 100-fold increase in affinity for exosite I when prothrombin was activated to thrombin. BJC efficiently displaced [5F]Hir(54-65)(SO(3)(-)) from complexes formed with thrombin or prothrombin with dissociation constants of 0.7 +/- 0.9 nM and 11 +/- 80 nM, respectively, indicating that BJC and Hir(54-65)(SO(3)(-)) compete for the same exosite on these molecules. The results indicate that BJC is a potent and specific probe of the partially exposed anion-binding exosite (proexosite I) of human prothrombin.

Citing Articles

Rattlesnake Roundup: Point-of-Care Thrombelastographic Methods Define the Molecular Impacts on Coagulation of Venom Toxins In Vitro and In Vivo.

Nielsen V Toxins (Basel). 2025; 17(2).

PMID: 39998104 PMC: 11860698. DOI: 10.3390/toxins17020087.

Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I.

Billur R, Ban D, Sabo T, Maurer M Biochemistry. 2017; 56(48):6343-6354.

PMID: 29111672 PMC: 6076386. DOI: 10.1021/acs.biochem.7b00970.

Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein.

Kroh H, Bock P J Biol Chem. 2012; 287(46):39149-57.

PMID: 23012355 PMC: 3493955. DOI: 10.1074/jbc.M112.415562.

Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model.

Carneiro-Lobo T, Konig S, Machado D, Nasciutti L, Forni M, Francischetti I J Thromb Haemost. 2009; 7(11):1855-64.

PMID: 19624457 PMC: 2896491. DOI: 10.1111/j.1538-7836.2009.03553.x.

Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.

Monteiro R, Rezaie A, Bae J, Calvo E, Andersen J, Francischetti I Protein Sci. 2007; 17(1):146-53.

PMID: 18042685 PMC: 2144593. DOI: 10.1110/ps.073016308.

References

Gitel S, Owen W, Esmon C, Jackson C . A polypeptide region of bovine prothrombin specific for binding to phospholipids. Proc Natl Acad Sci U S A. 1973; 70(5):1344-8. PMC: 433493. DOI: 10.1073/pnas.70.5.1344. View

Liu L, Vu T, Esmon C, Coughlin S . The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem. 1991; 266(26):16977-80. View

Dombrose F, Gitel S, Zawalich K, Jackson C . The association of bovine prothrombin fragment 1 with phospholipid. Quantitative characterization of the Ca2+ ion-mediated binding of prothrombin fragment 1 to phospholipid vesicles and a molecular model for its association with phospholipids. J Biol Chem. 1979; 254(12):5027-40. View

Walker F, Esmon C . The effect of prothrombin fragment 2 on the inhibition of thrombin by antithrombin III. J Biol Chem. 1979; 254(13):5618-22. View

Mann K, Elion J, Butkowski R, Downing M, Nesheim M . Prothrombin. Methods Enzymol. 1981; 80 Pt C:286-302. DOI: 10.1016/s0076-6879(81)80025-0. View

Bezeaud A, Denninger M, Guillin M . Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem. 1985; 153(3):491-6. DOI: 10.1111/j.1432-1033.1985.tb09328.x. View

Krstenansky J, Mao S . Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65. FEBS Lett. 1987; 211(1):10-6. DOI: 10.1016/0014-5793(87)81264-4. View

Hortin G, Tollefsen D, Benutto B . Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II. J Biol Chem. 1989; 264(24):13979-82. View

Atoda H, Morita T . A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization. J Biochem. 1989; 106(5):808-13. DOI: 10.1093/oxfordjournals.jbchem.a122935. View

10.

Naski M, Fenton 2nd J, Maraganore J, Olson S, Shafer J . The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. J Biol Chem. 1990; 265(23):13484-9. View

11.

Tulinsky A . The structures of domains of blood proteins. Thromb Haemost. 1991; 66(1):16-31. View

12.

Liu L, Ye J, Johnson A, Esmon C . Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site. J Biol Chem. 1991; 266(35):23633-6. View

13.

Ngai P, Chang J . A novel one-step purification of human alpha-thrombin after direct activation of crude prothrombin enriched from plasma. Biochem J. 1991; 280 ( Pt 3):805-8. PMC: 1130526. DOI: 10.1042/bj2800805. View

14.

Ye J, Liu L, Esmon C, Johnson A . The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem. 1992; 267(16):11023-8. View

15.

Bock P . Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of.... J Biol Chem. 1992; 267(21):14974-81. View

16.

Stubbs M, Bode W . A player of many parts: the spotlight falls on thrombin's structure. Thromb Res. 1993; 69(1):1-58. DOI: 10.1016/0049-3848(93)90002-6. View

17.

Arni R, Padmanabhan K, Padmanabhan K, Wu T, Tulinsky A . Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. Biochemistry. 1993; 32(18):4727-37. DOI: 10.1021/bi00069a006. View

18.

Karshikov A, Bode W, Tulinsky A, Stone S . Electrostatic interactions in the association of proteins: an analysis of the thrombin-hirudin complex. Protein Sci. 1992; 1(6):727-35. PMC: 2142249. DOI: 10.1002/pro.5560010605. View

19.

Sekiya F, Atoda H, Morita T . Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry. 1993; 32(27):6892-7. DOI: 10.1021/bi00078a012. View

20.

Ni F, Ning Q, Jackson C, Fenton 2nd J . Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin. J Biol Chem. 1993; 268(23):16899-902. View